The minimally-invasive and painless nature of microneedle (MN) application has enabled
the technology to obviate many issues with injectable drug delivery. MNs not only administer …

In recent years, a significant amount of drugs have been taken orally, which are not as
effective as desired. To solve this problem, bacterial cellulose-based dermal/transdermal …

Melanoma is a highly aggressive form of skin cancer with limited therapeutic options.
Chemo-photothermal combination therapy has demonstrated potential for effectively treating …

As the population is ageing and lifestyle is changing, the prevalence of musculoskeletal
(MSK) disorders is gradually increasing with each passing year, posing a serious threat to …

Methotrexate (MTX), a primary treatment for moderate to severe psoriasis, is limited in
clinical use due to suboptimal results and severe side effects from subcutaneous (SC) …

Abstract Parkinson's disease (PD), affecting millions of people worldwide and expected to
impact 10 million by 2030, manifests a spectrum of motor and non-motor symptoms linked to …

Microneedle (MN) technology is an optimal choice for the delivery of drugs via the
transdermal route, with a minimally invasive procedure. MN applications are varied from …

Innovation in the delivery system is a key tool for increasing the bioavailability of active
pharmaceutical ingredients (API). The oral route is the most promising and convenient route …

As a new type of transdermal drug delivery system (TDDS), microneedles have garnered
significant attention for their noninvasiveness, portability, controllable drug administration …

Background Despite its popularity, acceptability, and convenience, the oral route is not the
classical route for the administration of all critical bioactives including lipophilic drugs …